Skip to main content
Journal of General Internal Medicine logoLink to Journal of General Internal Medicine
editorial
. 2005 May;20(5):483–484. doi: 10.1111/j.1525-1497.2005.41013.x

TIME FOR “DRILLING DOWN”

Frank Vinicor 1
PMCID: PMC1490107  PMID: 15963178

In the ongoing battle against diseases such as diabetes mellitus (DM), we seem to progress through distinct phases. With the discovery of insulin,1 the view of diabetes changed from one of lethality and suffering to hope and a “cure”.2 Soon after, however, and into the middle 1970s, diabetes entered into a “chronic disease phase” with a sense of “inevitability” regarding devastating and deadly complications.2,3 The National Diabetes Act4 and the National Commission on Diabetes5 launched a 30 year phase of aggressive pursuit of greater understanding, discovery, and action, with A) emerging evidence of the size and scope of the diabetes burden;6 and B) convincing scientific efficacy evidence that both glucose control mattered;79 and that macrovascular disease did not have to happen among persons with DM.10 The beginning of the 21st century heralded two additional phases: A) evidence that the “epidemic” of DM is not only large, but still growing and international, and thus indicating an awareness of both individual AND society health and economic challenges;1113 and B) convincing scientific and economic evidence that in high-risk individuals at least, i.e. those with “prediabetes,” reduction in the incidence of type 2 DM is possible (if not also desirable and necessary!).1416

So perhaps some of the “big picture” of diabetes has become more clear – at least in the scientific, health care, political, private and popular communities:1719 on the one hand, DM is a big problem that is likely to get bigger before it gets smaller; and on the other hand, because of the efficacy evidence of the benefits of both improved care and primary prevention, we can, in fact, limit how big the problems of diabetes get and how long it stays big–before returning to baseline.

What does all this mean? Now, with the more general information as described above, it is time to “drill down”– to get below the surface and the “big picture;” to examine all the many and complex factors that will allow the establishment and wide dissemination of the effective care and prevention interventions which address diabetes. In this issue of the Journal of General Internal Medicine are several articles which address various dimensions of “the details” of the management and prevention of DM–how people feel about and function with their DM, as well as the use (or not!) of newer sources of information and knowledge about DM via the Internet;2022 how other common conditions very frequently associated with diabetes23,24–depression and cardiovascular disease – can and do impact on DM itself;25,26 and why tertiary prevention programs addressing a devastating complication of diabetes such as loss of vision–scientifically and economically validated almost 40 years ago!27–still has not resulted in widely available programs in the United States.28

Of special importance in several of these papers23,24 is the attention to issues of social justice for populations of Americans already struggling with so much about diabetes29–among many other challenging issues.3032

Each article has some limitation–cross sectional in design, small study populations, limited generalizeability, etc. But in the aggregate, they move forward in helping to identify the “deviling details,” which should be studied in subsequent investigations.

This “drilling down”–the efforts to now obtain more understanding below the surface of DM–is important in efforts not just to understand the condition, but to do more things in a better way to attenuate the individual and societal burden of DM 33,34. We always need to know more, but it does seem that in terms of DM, we know enough to greater and better action 35. The location of this action is quite clear. Will Sutton claimed that he robbed banks because that was where the money was! 36 Likewise, the “diabetes money” is in the hands of the “primary care bank”.37 But it will be the interactions among all the involved parties–primary care clinicians, specialists, patients, policy makers, private and public purchasers of care, communities, etc.–that will result in productive and accountable action.38 Care and prevention programs need to be expanded if ALL persons at risk for, or with DM, benefit.29 The “drilling down” should help immensely in improving any existing or anticipated interventions directed to the burden of DM.

References

  • 1.Bliss M. The Discovery of Insulin. Toronto: Mclelland & Stewart Ltd; 1982. [Google Scholar]
  • 2.Feudtner C. Chapel Hill, NC: University of North Carolina Press; 2003. Bitter Sweet: Diabetes, Insulin and the Transformation of Illness. [Google Scholar]
  • 3.American Diabetes Association. Alexandria, VA: American Diabetes Association; 1990. The Journey and the Dream: A History of the American Diabetes Association. [Google Scholar]
  • 4. National Diabetes Mellitus Research and Education Act, Public Law 93–354, U.S. Statutes at arge 88 (1974): 373.
  • 5. Report of the National Commission on Diabetes to the Congress of the United States. Long-Range Plan to Combat Diabetes. Diabetes Forecast, December 1975.
  • 6.Diabetes in America. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 95-1468. 2nd Edition, 1995.
  • 7.The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. doi: 10.1056/NEJM199309303291401. [DOI] [PubMed] [Google Scholar]
  • 8.Reichard P, Berglund B, Britz A, Cars I, Nilsson B, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med. 1991;230:101–8. doi: 10.1111/j.1365-2796.1991.tb00415.x. [DOI] [PubMed] [Google Scholar]
  • 9.UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–53. [PubMed] [Google Scholar]
  • 10.Fisher M. Vascular disease and diabetes: the change in emphasis in the last 20 years. Pract Diabetes International. 2004;21:73–7. [Google Scholar]
  • 11.King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
  • 12.Narayan KM, Boyle P, Thompson T, Sorensen S, Williamson D. Lifetime risk of diabetes mellitus in the United States. JAMA. 2003;290:1884–90. doi: 10.1001/jama.290.14.1884. [DOI] [PubMed] [Google Scholar]
  • 13.Hogan P, Dall T, Nikolov P. American Diabetes Association: Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32. doi: 10.2337/diacare.26.3.917. [DOI] [PubMed] [Google Scholar]
  • 14.Tuomilehto J, Linstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parrika P. Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med. 2001;344:1343–50. doi: 10.1056/NEJM200105033441801. [DOI] [PubMed] [Google Scholar]
  • 15.Knowler W, Barrett-Conner E, Fowler S, Hamman R, Lachin J, Walker E, et al. Reduction in the incidence of type 2 diabetes with lifestyle interventions or metformin. N Engl J Med. 2002;346:393–403. doi: 10.1056/NEJMoa012512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Vinicor F, Bowman B, Engelgua M. Diabetes prevention needed. Lancet. 2003;361 doi: 10.1016/S0140-6736(03)12561-5. [DOI] [PubMed] [Google Scholar]
  • 17.Piette J. The future of diabetes disease management: Integrating lessons learned from clinical, health services and policy research. Am J Managed Care. 2005;11:203–5. [PubMed] [Google Scholar]
  • 18. An American Epidemic: Diabetes. Newsweek, Sept. 4, 2000. [PubMed]
  • 19.Lazar M. How obesity causes diabetes: Not a tall tale. Science. 2005;307:373–375. doi: 10.1126/science.1104342. [DOI] [PubMed] [Google Scholar]
  • 20.Fan V, Reiber G, Diehr P, Burman M, McDonell M, Fihn S. Functional status and patient satisfaction: A comparison of ischemic heart disease, obstructive lung disease, and diabetes mellitus. J Gen Intern Med. 2005;20:452–59. doi: 10.1111/j.1525-1497.2005.40057.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vijan S, Hayward R, Ronis D, Hofer T. The burden of diabetes therapy: Implications for the design of effective patient-centered treatment regimens. J Gen Intern Med. 2005;20:479–82. doi: 10.1111/j.1525-1497.2005.0117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Grant R, Cagliero E, Chueh H, Meigs J. Internet use among primary care patients with type 2 diabetes: The generation and education gap. J Gen Intern Med. 2005;20:470–73. doi: 10.1111/j.1525-1497.2005.04239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gross R, Olfson M, Gameroff M, Carasquillo O, Shea S, Feder A, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005;20:460–66. doi: 10.1111/j.1525-1497.2005.30003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mohanty S, Woolhandler S, Himmelstein D. Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med. 2005;20:474–78. doi: 10.1111/j.1525-1497.2005.40294.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Katon W, Simon G, Russo J, Von Korff M, Lin E, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Medical Care. 2004;42:1222–29. doi: 10.1097/00005650-200412000-00009. [DOI] [PubMed] [Google Scholar]
  • 26.Marso S. Diabetes mellitus and vascular risk: Continuing the quest for the elusive keystone. Diabetes & Vasc Disease Res. 2005;2:7–8. doi: 10.3132/dvdr.2005.006. [DOI] [PubMed] [Google Scholar]
  • 27.Saaddine J, Venkat Narayan KM, Vinicor F. Vision loss: A public health problem? Ophthalmology. 2003;110:253–54. doi: 10.1016/s0161-6420(02)01839-0. [DOI] [PubMed] [Google Scholar]
  • 28.Hayward R, Cowan C, Giri V, Lawrence M, Makki F. Causes of preventable visual loss in type 2 diabetes mellitus: An evaluation of suboptimally timed retinal photocoagulation. J Gen Intern Med. 2005;20:467–69. doi: 10.1111/j.1525-1497.2005.40073.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Woolf S, Johnson R, Fryer G, Rust G, Satcher D. The health impact of resolving racial disparities: An analysis of US mortality data. Am J Public Health. 2004;94:2078–81. doi: 10.2105/ajph.94.12.2078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Marmot M. New York, NY: Times Books; 2004. The Status Syndrome: How Social Standing Affects Our Health and Longevity. [Google Scholar]
  • 31.Heisler M, Wagner E. Improving diabetes treatment quality in managed care organizations: Some progress, many challenges. Am J Managed Care. 2004;10:115–17. [PubMed] [Google Scholar]
  • 32.Becker G, Gates R, Newsom E. Self-care among chronically ill African Americans: Culture, health disparities, and health insurance status. Am J Pub Health. 2004;94:2066–73. doi: 10.2105/ajph.94.12.2066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vinicor F. Is diabetes a public-health disorder? Diabetes Care. 1994;17(Suppl 1):22–27. [PubMed] [Google Scholar]
  • 34.McGinnis JM. A vision for health in our new century. Am J Health Promotion. 2003;18:146–50. doi: 10.4278/0890-1171-18.2.146. [DOI] [PubMed] [Google Scholar]
  • 35.Harris J, Holman P, Carandi-Kulis V. Financial impact of health promotion: We need to know more, but we know enough to act. Am J Health Promotion. 2001;15:378–82. doi: 10.4278/0890-1171-15.5.378. [DOI] [PubMed] [Google Scholar]
  • 36.Willie Sutton, Edward Linn., editors. Toronto, Canada: Random House of Canada; 1976. Where the Money Was. [Google Scholar]
  • 37.Lipsky M, Sharp L. Preventive therapy for diabetes: Lifestyle changes and the primary care physician. Am Family Physician. 2004;69:269–71. [PubMed] [Google Scholar]
  • 38.Mascie-Taylor C, Karim E. The burden of chronic disease. Science. 2003;302:1921–22. doi: 10.1126/science.1092488. [DOI] [PubMed] [Google Scholar]

Articles from Journal of General Internal Medicine are provided here courtesy of Society of General Internal Medicine

RESOURCES